Clinical Trials Browser

Fibrosarcoma, Hyperinsulinism, Hypoglycemia, Insulinoma, Adenoma, Islet Cell, Liposarcoma, Neoplasms, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors

NCT07585032 2026-05-13

EUSRFAINSU

Recruiting

20 enrolled

Endocrine

Insulinoma

NCT03583528 2026-05-12

DOTATOC PET/CT for Imaging NET Patients

Active not recruiting

800 enrolled

CNSDermatologicEndocrineNETThoracic

Carcinoid Tumor, Vipoma, Ganglioneuroma, Glucagonoma, Insulinoma, Medulloblastoma, Meningioma, Neuroblastoma, Paraganglioma, Pheochromocytoma, Pituitary Neoplasms, Carcinoma, Merkel Cell, Gastrinoma, Carcinoma, Medullary, Neuroendocrine Tumors, Small Cell Lung Carcinoma

NCT01916148 2026-04-27

18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia

Available

Endocrine

Beckwith-Wiedemann Syndrome, Hyperinsulinism, Hypoglycemia, Insulinoma, Congenital Hyperinsulinism

NCT07340437 2026-01-15

Clinical Study of 18F-Exendin-4 in Insulinoma

Completed

20 enrolled

Endocrine

Insulinoma

NCT05735912 2026-01-13

ERASIN-RCT

Phase NA Active not recruiting

60 enrolled

Endocrine

Insulinoma

NCT05088798 2025-12-19

18FDOPA HI

Phase 2 Recruiting

100 enrolled

Endocrine

Hyperinsulinism, Hypoglycemia, Infant, Newborn, Diseases, Insulinoma, Glucose Metabolism Disorders

NCT07272187 2025-12-09

EURAGIL

Recruiting

138 enrolled

Endocrine

Hyperaldosteronism, Insulinoma

NCT07262970 2025-12-04

Intermediate-Size Cohort EAP for Ersodetug in Patients With Inadequately Controlled Hypoglycemia Related to a Tumor

Available

EndocrineNETSarcoma

Fibrosarcoma, Hyperinsulinism, Hypoglycemia, Insulinoma, Adenoma, Islet Cell, Liposarcoma, Neoplasms, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors

Clinical Trials

Tumor HI

EUSRFAINSU

DOTATOC PET/CT for Imaging NET Patients

18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia

Clinical Study of 18F-Exendin-4 in Insulinoma

ERASIN-RCT

18FDOPA HI

EURAGIL

Intermediate-Size Cohort EAP for Ersodetug in Patients With Inadequately Controlled Hypoglycemia Related to a Tumor